Introduction: Percutaneous transluminal angioplasty (PTA) is one of the treatment options for stenotic and obstructive lesions of the subclavian artery. Aim: To evaluate initial and long-term results of percutaneous transluminal angioplasty of subclavian artery lesions. Methods: During period February 2016 to December 2017, 26 patients (12 men and 14 women) with significant subclavian artery stenosis and occlusion were admitted and underwent PTA. All patients were symptomatic. All PTA procedures were performed with the patient under local anesthesia, through the femoral artery (n=22), brachial artery (n=4), or combined route (n=6). In 7 patients, we performed direct stenting, while in the other 15 patients we performed predilatation before stent implantation. The follow-up protocol consisted of regular clinical examinations in 1, 3, 6 and 12 months post-procedural, and annually thereafter with duplex ultrasound monitoring. Results: Initial technical success was achieved in 22 of 26 procedures (84.61%), 100% in stenotic lesions and 55.5 % in total occlusions. Fourth of nine occlusions could not be recanalized by PTA. These patients were managed surgically. The 30-day mortality rate was 0% for the entire group. No patients required reintervention for recurrence of symptoms and the stents remain patent at period of 12 months post-procedural. Conclusion: The minimal invasive technique, the markedly lower complication rate, the high long-term patency, patientís comfort and the decreased hospital stay have made endovascular repair the primary choice of treatment in the majority of cases, especially in patients with stenotic lesions and high-risk patients. We consider PTA of subclavian artery stenotic/obstructive lesions should be the Ô¨Ārst therapeutic option.
percutaneous transluminal angioplasty, subclavian artery lesions, subclavian steal phenomenon.
Assessment of structural brain changes in patients with type 2 diabetes mellitus using the MRI-based brain atrophy and lesion index.
Zhao H, Wang F, Luo GH, Lei H, Peng F, Ren QP, Chen W, Wu YF, Yin LC, Liu JC, Pan SN
Neural regeneration research. 2022; 17(3): 618-624
Procedures to Evaluate the Role of Heparan Sulfate on the Reactivity of Resistance and Conductance Arteries Ex Vivo.
Cho JM, Ly K, Ly S, Park SK, Babu PVA, Balagurunathan K, Symons JD
Methods in molecular biology (Clifton, N.J.). 2022; 2303(): 495-511
Ki20227 aggravates apoptosis, inflammatory response, and oxidative stress after focal cerebral ischemia injury.
Jiang C, Wang ZN, Kang YC, Chen Y, Lu WX, Ren HJ, Hou BR
Neural regeneration research. 2022; 17(1): 137-143
Inhibition of microRNA-29b suppresses oxidative stress and reduces apoptosis in ischemic stroke.
Ma YH, Deng WJ, Luo ZY, Jing J, Pan PW, Yao YB, Fang YB, Teng JF
Neural regeneration research. 2022; 17(2): 433-439
Rabbit Surgery Protocol for End-to-End and End-to-Side Vascular Graft Anastomosis.
Yao Y, Jeong Y, Zaw AM, Kukumberg M, Yim EKF
Methods in molecular biology (Clifton, N.J.). 2022; 2375(): 177-189